首页 | 本学科首页   官方微博 | 高级检索  
     

长春瑞滨联合顺铂治疗非小细胞肺癌的临床观察
引用本文:许大雪,许丹,于蕾,侯艳艳,刘茜. 长春瑞滨联合顺铂治疗非小细胞肺癌的临床观察[J]. 吉林医学, 2008, 29(23): 2170-2171
作者姓名:许大雪  许丹  于蕾  侯艳艳  刘茜
作者单位:吉林省肿瘤医院,吉林长春130000
摘    要:
目的:观察长春瑞滨联合顺铂治疗非小细胞肺癌的近期疗效和不良反应。方法:长春瑞滨30mg/m2,第一天和第8天静脉滴注;顺铂20mg/m2,1~5d静脉滴注,21d为1个周期,连用3个周期后评估结果。结果:共治疗的21例患者,其中CR1例,PR11例,总有效率为57.14%,主要不良反应为骨髓抑制,脱发及消化道反应。结论:长春瑞滨联合顺铂治疗非小细胞肺癌可获得较好疗效,不良反应可耐受,值得进一步推广。

关 键 词:长春瑞滨  顺铂  联合化疗  非小细胞肺癌

Combined chemotherapy of vinorelbine plus cisplatin in the treatment of NSCLC
XU Da-xue,XU Dan,YU Lei,et al. Combined chemotherapy of vinorelbine plus cisplatin in the treatment of NSCLC[J]. Jilin Medical Journal, 2008, 29(23): 2170-2171
Authors:XU Da-xue  XU Dan  YU Lei  et al
Affiliation:XU Da-xue,XU Dan,YU Lei,et al(Tumor Hospital of Jinlin Province,Changchun 130000,China)
Abstract:
Objective To evaluate the short-time effect and adverse reaction of vinorelbine plus cisplatin in the treatment of NSCLC.Method Vinorelbine: intravenous drip(30mg/m2),d1 and d8;cisplatin: intravenous drip(20mg/m2) d1~d4.One cycle lasted 21 days.Effect was evaluated after 3 cycles.Results Total 21 patients were treated.It showed that 1 case of CR and 11 cases of PR.The total effective rate was 57.14%.The main adverse reactions were myleosuppression,alopecia and digestive tract reaction.Conclusion The combine...
Keywords:Vinorelbine  Cisplatin  Combined chemotherapy  NSCLC  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号